Add to ORKGTo evaluate the association between psychotropic medication and inflammatory biomarkers in women with antenatal depressive symptoms (ADS). In this cross-sectional secondary analysis of a prospective multicenter observational study, 723 pregnant women underwent a depression screen using the Center for Epidemiologic Studies Depression Scale (CES-D) between 12 and 21 weeks gestation. Self-reported use of medications for depression and/or anxiety was corroborated with the medical record to document exposure to pharmacotherapy. Serum was collected and inflammatory biomarkers (IFNγ, IL13, IL6, IL8, TNFα, CRP) were measured concomitantly. Women were included if they fell into one of three categories: ADS responsive to treatment (CES-D < 16...
Background Maternal depression during pregnancy increases the risk for adverse developmental outcome...
Objective: Perinatal depressive symptoms often co-occur with other inflammatory morbidities of pregn...
Depressive symptoms in pregnancy are common, reported by approximately 20% of pregnant women worldwi...
BACKGROUND: Antenatal depression and use of serotonin reuptake inhibitors (SSRI) in pregnancy have b...
Perinatal depression affects 10-20% of women and is associated with poor outcomes for mother and chi...
Abstract Background Controversial findings regarding the association between pro-inflammatory cytoki...
Purpose. Increased inflammation has been described as consistently associated with depression. Moreo...
Background: Pregnant veterans are a subpopulation known to be at elevated risk of developing mental ...
A secondary pilot study was carried out as part of a larger parent study of thyroid function in preg...
Peripartum depression affects around 12% of women in pregnancy and postpartum, and about 2–3% of Eur...
Clinical studies suggest that psychiatric symptoms, particularly depression, anxiety and trauma, may...
Postpartum depression (PPD) is a devastating disorder affecting not only more than 10% of all women ...
Background: Antepartum depression is one of the leading causes of maternal morbidity and mortality i...
Peripartum depression is a common, multifactorial, and potentially devastating disease among new mot...
Background Maternal depression during pregnancy increases the risk for adverse developmental outcome...
Objective: Perinatal depressive symptoms often co-occur with other inflammatory morbidities of pregn...
Depressive symptoms in pregnancy are common, reported by approximately 20% of pregnant women worldwi...
BACKGROUND: Antenatal depression and use of serotonin reuptake inhibitors (SSRI) in pregnancy have b...
Perinatal depression affects 10-20% of women and is associated with poor outcomes for mother and chi...
Abstract Background Controversial findings regarding the association between pro-inflammatory cytoki...
Purpose. Increased inflammation has been described as consistently associated with depression. Moreo...
Background: Pregnant veterans are a subpopulation known to be at elevated risk of developing mental ...
A secondary pilot study was carried out as part of a larger parent study of thyroid function in preg...
Peripartum depression affects around 12% of women in pregnancy and postpartum, and about 2–3% of Eur...
Clinical studies suggest that psychiatric symptoms, particularly depression, anxiety and trauma, may...
Postpartum depression (PPD) is a devastating disorder affecting not only more than 10% of all women ...
Background: Antepartum depression is one of the leading causes of maternal morbidity and mortality i...
Peripartum depression is a common, multifactorial, and potentially devastating disease among new mot...
Background Maternal depression during pregnancy increases the risk for adverse developmental outcome...
Objective: Perinatal depressive symptoms often co-occur with other inflammatory morbidities of pregn...
Depressive symptoms in pregnancy are common, reported by approximately 20% of pregnant women worldwi...